ASTCT Talks is the official podcast of the American Society for Transplantation and Cellular Therapy (ASTCT). We chat with industry leaders from all areas of the blood and marrow transplantation and cellular therapy field, including doctors, physician assistants, pharmacists, nurses, administrators, social workers, and more. We hope you enjoy listening!

ASTCT Talks
Claim This Podcastby ASTCT
Podcast Authority
Beta
Podcast Overview
ASTCT Talks is the official podcast of the American Society for Transplantation and Cellular Therapy (ASTCT). We chat with industry leaders from all areas of the blood and marrow transplantation and cellular therapy field, including doctors, physician assistants, pharmacists, nurses, administrators, social workers, and more. We hope you enjoy listening!
Language
🇺🇲
Publishing Since
11/12/2020
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
Beta
Recommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
1 verified contact email on file for ASTCT Talks
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes

May 20, 2026
ASTCT Talks: Gene Therapy Today and Tomorrow
<p>Gene therapy is changing how clinicians care for patients with rare and genetic diseases, with more therapies moving from research into clinical use. In this episode, Dr. Nirali Shah is joined by Dr. Christy Duncan and Dr. Sung‑Yun Pai to talk through recent progress in the field and what it actually takes to deliver these treatments at the patient level.</p><p>The discussion draws on their experience in transplant and genetic disease, covering both scientific advances and the operational challenges that come with implementing gene therapy — especially in complex and resource‑intensive settings. </p><p>Tune in for a conversation that covers:</p><ul><li>Recent developments in gene therapy, including in vivo approaches and newly approved treatments</li><li>Barriers to broader use, including access, equity, and long-term monitoring</li><li>What centers need to consider when building a gene therapy program, from workflows to team coordination</li><li>Where things may be heading, including more individualized therapies and efforts to expand availability</li></ul><p>Listen to the episode below or on your favorite app. Subscribe to ASTCT Talks and share this episode with your colleagues to keep the conversation going.</p>

March 31, 2026
Treatment Options for cGVHD: Adult vs. Pediatric Perspectives
<p>In this episode of ASTCT Talks, host Corey Cutler, MD of Dana-Farber Cancer Institute and Harvard University sits down with Nosha Farhadfar, MD, medical director of research for Sarah Cannon Research Institute’s transplant and cellular therapy program at Methodist Healthcare, and Pooja Khandelwal, MD, an associate professor within the division of bone marrow transplantation at Cincinnati Children’s Hospital Medical Center, to discuss adult and pediatric treatment perspectives for cGVHD.</p><p>Tune in for a conversation that covers:</p><ul><li>Adult and pediatric cGVHD treatment approaches,including frontline choices and the selection and effectiveness of medications.</li><li>Expert practice experiences for use in cGVHD treatment.</li><li>New therapeutics the experts are looking forward to in cGVHD treatment. </li></ul><p>This episode was made possible thanks to a grant from Incyte. </p>

January 13, 2026
Best Practice Considerations for Infection Prevention and Management Post-CAR T
<p>In this episode of ASTCT Talks, host Terri Lynn Shigle, PharmD(The University of Texas MD Anderson Cancer Center; Pharmacy SIG Immediate Past-Chair), sits down with Zainab Shahid, MD (Memorial Sloan Kettering Cancer Center; ID SIG Chair), and Gabriela Maron, MD (St. Jude Children’s ResearchHospital). As coauthors of the ASTCT Practice Guidelines, "<a href="https://www.astctjournal.org/article/S2666-6367(25)01259-X/fulltext">American Society for Transplantation and Cellular Therapy Best Practice Considerations for the Prevention and Management of Infections After Chimeric Antigen Receptor T-Cell Therapy for Hematological Malignancies</a>," recently published in Transplantation and Cellular Therapy, they discuss the implementation of critical strategies for safeguarding CAR T recipients.</p><p>The conversation explores the nuances of the manuscript,providing a practical perspective on translating these consensus recommendations into clinical operations.</p><ul><li><strong>Assessing the Burden of Immunosuppression</strong>: Evaluating the cumulative risk factors that predispose CAR T recipients to infection, including heavy pretreatment and the effects of lymphodepletion.</li></ul><ul><li><strong>Prophylaxis Optimization</strong>: Critical considerations regarding the timing, selection, and duration of antimicrobial regimens in the post-CAR T setting.</li></ul><ul><li><strong>Managing Hypogammaglobulinemia: </strong>A pragmatic look at IVIG replacement strategies, balancing emerging clinical evidence with institutional protocols and global product shortages.</li><li><strong>Addressing Evidence Gaps: </strong>Insider insights into the expert panel’s deliberations on "grey areas," such as the management of CMV reactivation and optimal post-therapy vaccination schedules.</li><li><strong>The Pediatric-Adult Continuum: </strong>Ensuring that prevention and management strategies are robust and applicable across the full age spectrum of CAR-T recipients.</li></ul><ul><p>This episode provides essential context for cliniciansseeking to move beyond the published guidelines and operationalize these bestpractices with greater precision and confidence.</p><p>Thank you to Johnson & Johnson and Legend Biotech forsupporting this episode.</p></ul><p><br></p><p></p><ul> </ul><p></p><ul><ul> </ul></ul>
72 total episodes available
Recent guests on ASTCT Talks
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Dr Daniel Weisdorf
Guest
Rahul Banerjee
Guest
Taha Al-Juhaishi
Guest
Muhammad Salman Faisal
Guest
Dr Taha Al-Juhaishi
Guest
Deep-dive analytics for ASTCT Talks
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is ASTCT Talks?
- How often does this podcast release new episodes?
This podcast updates bi-weekly.
- Where can I listen to this podcast?
This podcast is available on 8 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.





